A detailed history of Financial Freedom, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Freedom, LLC holds 106 shares of ABBV stock, worth $17,651. This represents 0.01% of its overall portfolio holdings.

Number of Shares
106
Previous 105 0.95%
Holding current value
$17,651
Previous $16.3 Million 18.56%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $159 - $182
1 Added 0.95%
106 $19.3 Million
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $137 - $154
1 Added 0.96%
105 $16.3 Million
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $133 - $154
1 Added 0.97%
104 $15.5 Million
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $132 - $164
1 Added 0.98%
103 $13.9 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $867 - $999
-6 Reduced 5.56%
102 $16.2 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $14,937 - $17,913
108 New
108 $17.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Freedom, LLC Portfolio

Follow Financial Freedom, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Freedom, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Freedom, LLC with notifications on news.